Canna~Fangled Abstracts Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2018 Dec 13. pii: S1474-4422(18)30406-X. doi: 10.1016/S1474-4422(18)30406-X. Riva N1, Mora G2, Sorarù G3,…Freedom WaresDecember 13, 2018